- Article
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
- Júlia Companys-Alemany,
- Andreea L. Turcu,
- Aina Bellver-Sanchis,
- Maria I Loza,
- José M. Brea,
- Anna M Canudas,
- Rosana Leiva,
- Santiago Vázquez,
- Mercè Pallàs and
- Christian Griñán-Ferré
Alzheimer’s disease (AD) is the leading cause of dementia. Non-competitive N-Methyl-D-aspartate (NMDA) receptor antagonist memantine improved cognition and molecular alterations after preclinical treatment. Nevertheless, clinical results are di...

